Co-Authors
This is a "connection" page, showing publications co-authored by Sreedhar Subramanian and Philip Smith.
Connection Strength
0.290
-
From intravenous to subcutaneous infliximab in patients with inflammatory bowel disease: a pandemic-driven initiative. Lancet Gastroenterol Hepatol. 2021 02; 6(2):88-89.
Score: 0.232
-
SARS-CoV-2 vaccination for patients with inflammatory bowel disease: a British Society of Gastroenterology Inflammatory Bowel Disease section and IBD Clinical Research Group position statement. Lancet Gastroenterol Hepatol. 2021 03; 6(3):218-224.
Score: 0.058